Novel HIV-1 therapeutics through targeting altered host cell pathways.
about
The Road Less Traveled: HIV's Use of Alternative Routes through Cellular PathwaysStructural insights of non-canonical U*U pair and Hoogsteen interaction probed with Se atomCyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathwaysDrug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory TrialThe identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patients.Transcriptome Analysis Reveals Novel Entry Mechanisms and a Central Role of SRC in Host Defense during High Multiplicity Mycobacterial InfectionHIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse.Nelfinavir impairs glycosylation of herpes simplex virus 1 envelope proteins and blocks virus maturationCellular networks involved in the influenza virus life cycle.The human transcriptome during nontyphoid Salmonella and HIV coinfection reveals attenuated NFkappaB-mediated inflammation and persistent cell cycle disruption.Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirusPatented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor.Host cell factors as antiviral targets in arenavirus infection.Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.HIV-1 replication and latency are regulated by translational control of cyclin T1Targeting HIV transcription: the quest for a functional cure.Computer-aided design, synthesis and validation of 2-phenylquinazolinone fragments as CDK9 inhibitors with anti-HIV-1 Tat-mediated transcription activity.Inhibition of HIV-1 replication with stable RNAi-mediated knockdown of autophagy factors.Interplay between Autophagy, Exosomes and HIV-1 Associated Neurological Disorders: New Insights for Diagnosis and Therapeutic Applications.Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity.Research highlights on a notable retrovirus and a popular guardian gene.Cyclin E goes nuts: a cell cycle regulator affects male fertility.
P2860
Q27027607-1B7A958F-DB80-4AC2-8E7D-A430314C2085Q27679886-5C3B45C5-84D0-4FF3-8386-50007835B86DQ28483731-297A3152-9150-4A45-BC23-621C7501E8ABQ28552171-1B77EBD4-1512-4707-8F0E-68848D54F058Q33626049-196A81F6-CE7B-4A84-A550-E6807AC54F90Q34793396-239003FB-EB93-4C36-9CF5-9F34092FA204Q34990993-3D623897-428E-4A1A-9D9C-285550FF22AFQ35077455-50776600-6967-4735-B47F-2845924BC854Q35196542-0A68AD63-7B7A-4504-A303-D71A81F524C9Q35214153-5F6FF08D-B7AD-445F-9FCE-77C888F9672CQ36872701-71C748CB-6990-4659-8394-C3B35D94E893Q37812614-0348371F-A9A4-4308-8B50-47CB9E00FC6EQ38061425-D7C5EA68-8A02-416F-A5C3-6D89B829C3BFQ38212101-51F07BD8-C10E-4ECE-8B9B-5F8F92E04F88Q38273477-BC333FA1-D191-42EB-A26F-7823A72007A5Q38366762-A8B78799-88EF-410A-91E7-E1182A9AD2E4Q39073158-95E77E71-BFC0-467B-A4A9-833F4C44ABF2Q39378609-B25284EB-F62C-4B75-B4CB-9F3F97F4ACB9Q39419450-D3ED9F11-8856-4A92-B78E-4E3FB29F3A02Q39543548-48F8035F-1648-4ED2-9695-1AA318AC71C0Q43006056-EE61ADA6-522E-4516-AA6D-D496CFEBDECDQ53273895-BD2C597B-EC52-495A-B2F3-2C8052F7DF95
P2860
Novel HIV-1 therapeutics through targeting altered host cell pathways.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Novel HIV-1 therapeutics through targeting altered host cell pathways.
@en
Novel HIV-1 therapeutics through targeting altered host cell pathways.
@nl
type
label
Novel HIV-1 therapeutics through targeting altered host cell pathways.
@en
Novel HIV-1 therapeutics through targeting altered host cell pathways.
@nl
prefLabel
Novel HIV-1 therapeutics through targeting altered host cell pathways.
@en
Novel HIV-1 therapeutics through targeting altered host cell pathways.
@nl
P2093
P2860
P1476
Novel HIV-1 therapeutics through targeting altered host cell pathways.
@en
P2093
Fatah Kashanchi
Rachel Van Duyne
William Coley
P2860
P304
P356
10.1517/14712590903257781
P407
P577
2009-11-01T00:00:00Z